Cargando…

Evaluating the Nephrotoxicity of Area-under-the-Curve-Based Dosing of Vancomycin with Concomitant Antipseudomonal Beta-Lactam Antibiotics: A Systematic Review and Meta-Analysis

Background and Objectives: Vancomycin combined with piperacillin/tazobactam (vancomycin + piperacillin/tazobactam) has a higher risk of acute kidney injury (AKI) than vancomycin combined with cefepime or meropenem. However, it is uncertain if applying area under the curve (AUC)-based vancomycin dosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiu, Chia-Yu, Sarwal, Amara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146400/ https://www.ncbi.nlm.nih.gov/pubmed/37109649 http://dx.doi.org/10.3390/medicina59040691

Ejemplares similares

Antipseudomonal β-Lactams Resistance in Iran
por: Rabiei, Mohammad Mahdi, et al.
Publicado: (2020)

Piperacillin–Tazobactam Plus Vancomycin-Associated Acute Kidney Injury in Adults: Can Teicoplanin or Other Antipseudomonal Beta-Lactams Be Remedies?
por: Aslan, Abdullah Tarık, et al.
Publicado: (2022)

1570. Association Between Vancomycin Area Under the Curve (AUC) and Nephrotoxicity
por: Poston-Blahnik, Anna, et al.
Publicado: (2019)

757 Comparison of Nephrotoxicity in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Beta-lactams or Vancomycin
por: Streifel, Amber, et al.
Publicado: (2014)

Evaluation of the Empiric use of Levofloxacin in Combination with Antipseudomonal Β-Lactams for the Treatment of Pneumonia
por: Bachna, Jon, et al.
Publicado: (2017)

An evaluation of antipseudomonal dosing on the incidence of treatment failure
por: Hawkins, Brandon K, et al.
Publicado: (2021)

Association between duration of antipseudomonal beta-lactam therapy and Clostridioides difficile infections in monomicrobial Enterobacterales bloodstream infections at an academic medical center
por: Hawkins, Audry M., et al.
Publicado: (2022)

Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?
por: Van Herendael, Bruno, et al.
Publicado: (2012)

2175. In vitro Potency of Ceftolozane/Tazobactam and Other Antipseudomonal β-Lactams Against P. aeruginosa
por: Abuhussain, Safa Almarzoky, et al.
Publicado: (2018)

Mortality in patients with carbapenem-resistant Pseudomonas aeruginosa with and without susceptibility to traditional antipseudomonal β-lactams
por: Howard-Anderson, Jessica, et al.
Publicado: (2021)

Beta-lactam antibiotic test doses in the emergency department
por: Maguire, Michelle, et al.
Publicado: (2020)

Clinical Outcomes of Antipseudomonal vs. Non-Antipseudomonal Therapy in Patients with Osteomyelitis
por: Jansen, Jeffrey W, et al.
Publicado: (2017)

The Nephrotoxicity of Vancomycin
por: Filippone, EJ, et al.
Publicado: (2017)

Relation between Resistance to Antipseudomonal β-Lactams and ampC and mexC Genes of Pseudomonas aeruginosa
por: Rezaei, Fatemeh, et al.
Publicado: (2016)

Effective Dosage of Oral Vancomycin in Treatment for Initial Episode of Clostridioides difficile Infection: A Systematic Review and Meta-Analysis
por: Chiu, Chia-Yu, et al.
Publicado: (2019)

Vancomycin Loading Doses and Nephrotoxicity on Medicine Teaching Services
por: Wagner, Phillip, et al.
Publicado: (2022)

1391. Vancomycin Area Under the Curve (AUC) to Predict Nephrotoxicity: A Systematic Review and Meta-Analysis of Observational Studies
por: Aljefri, Doaa, et al.
Publicado: (2018)

Determinants of empirical antipseudomonal antibiotic prescription for adults with pneumonia in the emergency department
por: Angrill, Nuria, et al.
Publicado: (2020)

125. Induction of Resistance Against Antipseudomonal Agents: Comparison of Novel b-Lactam/b-Lactamase Inhibitor (BL/BLI) Combinations and Other b-lactam Agents
por: Castanheira, Mariana, et al.
Publicado: (2022)

Performance of Antipseudomonal β-Lactams on the Accelerate PhenoTest BC Kit against a Collection of Pseudomonas aeruginosa Isolates
por: Sikorski, Aaron, et al.
Publicado: (2021)

Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity
por: Tantranont, Ngoentra, et al.
Publicado: (2021)

Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA).
por: Kim, Yeon Sook, et al.
Publicado: (2003)

1575. Vancomycin Loading Doses and Nephrotoxicity on Medicine Teaching Services
por: Wagner, Phillip, et al.
Publicado: (2019)

1929. Risk of Acute Kidney Injury in Combat-Injured Patients Associated With Concomitant Vancomycin and Extended-Spectrum β-Lactam Antibiotic Use
por: Yabes, Joseph, et al.
Publicado: (2018)

834. Clinical Outcomes with Carbapenem-Resistant Pseudomonas aeruginosa that Retain Susceptibility to Traditional Antipseudomonal β-lactams: Atlanta, 2016-2018
por: Howard-Anderson, Jessica, et al.
Publicado: (2020)

Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia: A systematic review and Bayesian network meta-analysis
por: Tan, Xinmei, et al.
Publicado: (2021)

162. Assessment of Beta-lactam Allergies as Rationale for Receipt of Vancomycin for Surgical Prophylaxis
por: Tucker, Kendall J, et al.
Publicado: (2020)

598. Area under the curve-guided vancomycin monitoring and risk of nephrotoxicity in non-Staphylococcus aureus infections: A case-control study
por: Mazewski, Douglas, et al.
Publicado: (2022)

Area-Under-Curve–Guided Versus Trough-Guided Monitoring of Vancomycin and Its Impact on Nephrotoxicity: A Systematic Review and Meta-Analysis
por: Lim, Ashley Shiyuan, et al.
Publicado: (2023)

THE BETA-LACTAM ANTIBIOTICS: Penicillins and Cephalosporins in Perspective
Publicado: (1980)

Use of beta-lactams antibiotics in ICU patients
por: Damas, M-P, et al.
Publicado: (2015)

67. Agreement Among Bayesian Dosing Software for Calculating Vancomycin Area Under the Curve
por: Pineda, Ross, et al.
Publicado: (2021)

1645. Predicting Vancomycin Area Under the Curve by Bayesian-Guided Dosing in Pediatric Patients
por: Shin, Donghyun, et al.
Publicado: (2023)

Variation in Target Attainment of Beta‐Lactam Antibiotic Dosing Between International Pediatric Formularies
por: Gastine, Silke, et al.
Publicado: (2021)

Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the ‘Maximum Tolerable Dose’
por: Dhaese, Sofie A. M., et al.
Publicado: (2022)

Addition of probenecid to oral β-lactam antibiotics: a systematic review and meta-analysis
por: Wilson, Richard C, et al.
Publicado: (2022)

Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics
por: Zmarlicka, Monika T, et al.
Publicado: (2015)

Suspected allergy to Beta-Lactam antibiotics: An infectiological perspective
por: Sunderkötter, Cord
Publicado: (2022)

Cephalosporins as key lead generation beta-lactam antibiotics
por: Lin, Xuemei, et al.
Publicado: (2022)

Hospital-level variation in the utilization of antipseudomonal antibiotics: A nationwide cross-sectional study at the VHA
por: Hasegawa, Shinya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_utpijsu6dg1u3ftkisih1lacqr